FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

23634011000001104: Alogliptin 6.25mg tablets 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jan 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
77138701000001111 Alogliptin 6.25mg tablets 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
77138801000001119 Alogliptin 6.25mg tablets 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alogliptin 6.25mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets 28 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets 28 tablet Has VMP Alogliptin 6.25mg tablets true Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets 28 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets 28 tablet Has specific active ingredient Alogliptin benzoate false Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Alogliptin false Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets 28 tablet Has specific active ingredient Alogliptin benzoate true Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Alogliptin true Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets 28 tablet Has basis of strength substance Alogliptin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vipidia 6.25mg tablets (Pharmaram Ltd) 28 tablet Is a True Alogliptin 6.25mg tablets 28 tablet Inferred relationship Existential restriction modifier
Vipidia 6.25mg tablets (CST Pharma Ltd) 28 tablet Is a True Alogliptin 6.25mg tablets 28 tablet Inferred relationship Existential restriction modifier
Vipidia 6.25mg tablets (DE Pharmaceuticals) 28 tablet Is a True Alogliptin 6.25mg tablets 28 tablet Inferred relationship Existential restriction modifier
Vipidia 6.25mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets Is a True Alogliptin 6.25mg tablets 28 tablet Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets (Ennogen Healthcare Ltd) 28 tablet Is a False Alogliptin 6.25mg tablets 28 tablet Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets (J M McGill Ltd) 28 tablet Is a False Alogliptin 6.25mg tablets 28 tablet Inferred relationship Existential restriction modifier
Alogliptin 6.25mg tablets (Niche Pharma Ltd) 28 tablet Is a False Alogliptin 6.25mg tablets 28 tablet Inferred relationship Existential restriction modifier
Vipidia 6.25mg tablets (Originalis B.V.) 28 tablet Is a True Alogliptin 6.25mg tablets 28 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start